What's New

Medical News
& Alerts

Conferences
& Meetings


Other Medical
Resources

Employment
Opportunities

Partnering
Opportunities

Search results for: Bayer
96%DGNews: Alliance To Develop Treatments and Educational Programs for Alzheimer
95%DGNews: Kogenate (Antihemophilic Factor) with Bio-Set Approved by European Union
95%DGNews: Two Lots of Gamimune N (Immune Globulin) Recalled Due To Tampering
95%DGNews: Canada To Be Major Player in International Angina Research
95%DGNews: Bayer Issues Statement on Debate at AHA Meeting
95%DGNews: Precose Now Available For Type II Diabetes Patients
94%DGNews: Bayer Wins Approval for Avelox (Moxifloxacin) in Japan
94%DGNews: Bayer and GlaxoSmithKline Announce "Levitra" as Global Trade Name for New Investigational Erectile Dysfunction Treatment
94%DGNews: Bayer seeks Pediatric Cystic Fibrosis Indication for Cipro
94%DGNews: New 100mg Cipro Tablets for Acute Uncomplicated Cystitis in Females
94%DGNews: Glyset Cleared by FDA Provides Important, New Diabetes Treatment Option
94%DGNews: Cipro Approved For Treatment Of Acute Sinusitis
94%DGNews: FDA Proposes Professional Labeling for New Lifesaving Benefit of Aspirin
94%DGNews: WHO Calls For Screening Of Emphysema, Chronic Bronchitis And Asthma
94%DGNews: Self-Confidence Up...But Sex Drive & Health are Down For 50-Year-Olds
93%DGNews: Bayer Withdraws Liquid Formulation of Leukine (sargramostim) in US Due to Adverse Reactions
93%DGNews: Health Canada Issues an Update on Availability of Trasylol (aprotinin)
93%DGNews: Nexavar Approved in Switzerland for the Treatment of Patients with Advanced Kidney Cancer
93%DGNews: Bayer Issues Letter to Health Care Professionals in Canada Regarding Trasylol (Aprotinin)
93%DGNews: FDA Approves Gamunex, Immune Globulin Intravenous (Human), 10% Caprylate/Chromatography Purified
93%DGNews: Canada Approves Gamunex, Immune Globulin Intravenous (Human)
93%DGNews: European Commission Approves Levitra (Vardenafil HCl) For Treatment Of Erectile Dysfunction
93%DGNews: Levitra (Vardenafil) Receives Positive Opinion From European Committee For Proprietary Medicinal Products
93%DGNews: An Aspirin (ASA) A Day Keeps First Heart Attack Away - Health Canada Confirms It
93%DGNews: Bayer Voluntarily Pulls Baycol (Cerivastatin) From Markets Worldwide
93%DGNews: Baycol/Lipobay (Cerivastatin) Withdrawn From World Market
93%DGNews: CIPRO Cleared by FDA to Treat Complicated Intra-Abdominal Infections
93%DGNews: FDA Urged to Expand Uses for Aspirin
93%DGNews: Gamimune to Fight Bacteria and Infection
92%DGNews: Levitra (Vardenafil HCl), Treatment Option For Erectile Dysfunction, To Launch In Europe This Month
92%DGNews: FDA Approves Avelox (Moxifloxacin HCl) For Community Acquired Pneumonia Due To Penicillin-Resistant Streptococcus Pneumoniae
92%DGNews: FDA Approves Once-Daily Cipro (Ciprofloxacin) XR For Uncomplicated Urinary Tract Infections
92%DGNews: Bayer Inc. - Notice of Retraction/Clarification
92%DGNews: Alzheimer's Stroke Link Suggests Aspirin's Benefits Says Study
92%DGNews: FDA Approved Kogenate FS Antihemophilic Factor (Recombinant) For Hemophilia A
92%DGNews: Doctors Get Rx For Improving Management of U.S.'s Fourth Leading Killer
92%DGNews: FDA Committee Recommends Avelox For Respiratory Tract Infections
92%DGNews: Milestone in the Treatment of Hypertensive Patients
91%DGNews: FDA Requests Marketing Suspension of Trasylol
91%DGNews: Nexavar (Sorafenib) Approved by European Commission for the Treatment of Advanced Kidney Cancer
91%DGNews: Bayer Receives FDA Approval for Room Temperature Storage of Kogenate FS (Antihemophilic Factor (Recombinant)
91%DGNews: FDA Grants Cipro (Ciprofloxacin) Additional Six Months Marketing Exclusivity
91%DGNews: Canada Approves Aspirin (Acetylsalicylic Acid) for Use During Heart Attack
91%DGNews: AVELOX (Moxifloxacin HCl) Approved For The Treatment Of Respiratory Tract Infections
91%DGNews: Link Shown Between Inflammation and Heart Attack
90%DGNews: Bayer Removes Remaining Stocks of Aprotinin; Access Limited to Investigational Use
90%DGNews: Bayer Discontinues Trasylol® (Aprotinin Injection) Clinical Trial Program in Non-CABG Indications
90%DGNews: FDA Advisory Committee Strongly Endorses Use of Trasylol in CABG Surgery Patients
90%DGNews: Nexavar Receives Positive Opinion from European Committee for Medicinal Products for Human Use
90%DGNews: European Commission Grants Orphan Medicinal Product Designation to Nexavar for the Treatment of Hepatocellular Carcinoma
Enter keywords you wish to find information about:

Search for documents that contain:
any of these words.
this exact phrase.
all of these words.

 

 

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.

All contents Copyright (c) 1998 PSL Consulting Group Inc.
all rights reserved.